vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and QUAKER CHEMICAL CORP (KWR). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $468.5M, roughly 1.6× QUAKER CHEMICAL CORP). QUAKER CHEMICAL CORP runs the higher net margin — 4.4% vs 3.6%, a 0.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 5.5%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -0.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Quaker Chemical Corporation, doing business as Quaker Houghton, is an American chemical company that was founded in 1918. It is headquartered in Conshohocken, Pennsylvania. With its global presence in 21 countries and 35 locations worldwide, the company has over 50% of net sales outside of the United States. Quaker Houghton manufactures process fluids for use in the steel, aluminum, metalworking, automotive, mining, aerospace, tube & pipe, can making, and other industrial processes. On August...

CLOV vs KWR — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.6× larger
CLOV
$749.2M
$468.5M
KWR
Growing faster (revenue YoY)
CLOV
CLOV
+56.6% gap
CLOV
62.0%
5.5%
KWR
Higher net margin
KWR
KWR
0.8% more per $
KWR
4.4%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-0.1%
KWR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
KWR
KWR
Revenue
$749.2M
$468.5M
Net Profit
$27.3M
$20.7M
Gross Margin
35.3%
Operating Margin
3.6%
6.7%
Net Margin
3.6%
4.4%
Revenue YoY
62.0%
5.5%
Net Profit YoY
45.9%
EPS (diluted)
$0.05
$1.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
KWR
KWR
Q1 26
$749.2M
Q4 25
$487.7M
$468.5M
Q3 25
$496.6M
$493.8M
Q2 25
$477.6M
$483.4M
Q1 25
$462.3M
$442.9M
Q4 24
$337.0M
$444.1M
Q3 24
$331.0M
$462.3M
Q2 24
$356.3M
$463.6M
Net Profit
CLOV
CLOV
KWR
KWR
Q1 26
$27.3M
Q4 25
$-49.3M
$20.7M
Q3 25
$-24.4M
$30.5M
Q2 25
$-10.6M
$-66.6M
Q1 25
$-1.3M
$12.9M
Q4 24
$-22.1M
$14.2M
Q3 24
$-9.2M
$32.3M
Q2 24
$7.4M
$34.9M
Gross Margin
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
35.3%
Q3 25
36.6%
Q2 25
35.5%
Q1 25
36.4%
Q4 24
35.2%
Q3 24
24.5%
37.3%
Q2 24
30.3%
37.9%
Operating Margin
CLOV
CLOV
KWR
KWR
Q1 26
3.6%
Q4 25
-10.1%
6.7%
Q3 25
-4.9%
9.4%
Q2 25
-2.2%
-10.9%
Q1 25
-0.3%
6.2%
Q4 24
-6.4%
6.5%
Q3 24
-2.7%
11.2%
Q2 24
2.0%
12.6%
Net Margin
CLOV
CLOV
KWR
KWR
Q1 26
3.6%
Q4 25
-10.1%
4.4%
Q3 25
-4.9%
6.2%
Q2 25
-2.2%
-13.8%
Q1 25
-0.3%
2.9%
Q4 24
-6.6%
3.2%
Q3 24
-2.8%
7.0%
Q2 24
2.1%
7.5%
EPS (diluted)
CLOV
CLOV
KWR
KWR
Q1 26
$0.05
Q4 25
$1.16
Q3 25
$1.75
Q2 25
$-3.78
Q1 25
$0.73
Q4 24
$0.81
Q3 24
$1.81
Q2 24
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
KWR
KWR
Cash + ST InvestmentsLiquidity on hand
$177.6M
$179.8M
Total DebtLower is stronger
$834.9M
Stockholders' EquityBook value
$339.4M
$1.4B
Total Assets
$697.7M
$2.8B
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
KWR
KWR
Q1 26
$177.6M
Q4 25
$78.3M
$179.8M
Q3 25
$172.0M
Q2 25
$201.9M
Q1 25
$186.2M
Q4 24
$194.5M
$188.9M
Q3 24
$288.0M
$212.1M
Q2 24
$254.8M
$188.6M
Total Debt
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
$834.9M
Q3 25
Q2 25
Q1 25
Q4 24
$669.6M
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
KWR
KWR
Q1 26
$339.4M
Q4 25
$308.7M
$1.4B
Q3 25
$340.9M
$1.4B
Q2 25
$344.2M
$1.3B
Q1 25
$336.1M
$1.4B
Q4 24
$341.1M
$1.4B
Q3 24
$342.2M
$1.4B
Q2 24
$324.9M
$1.4B
Total Assets
CLOV
CLOV
KWR
KWR
Q1 26
$697.7M
Q4 25
$541.0M
$2.8B
Q3 25
$559.7M
$2.8B
Q2 25
$575.0M
$2.8B
Q1 25
$583.7M
$2.7B
Q4 24
$580.7M
$2.6B
Q3 24
$653.0M
$2.7B
Q2 24
$674.2M
$2.7B
Debt / Equity
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
0.61×
Q3 25
Q2 25
Q1 25
Q4 24
0.49×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
KWR
KWR
Operating Cash FlowLast quarter
$46.5M
Free Cash FlowOCF − Capex
$24.3M
FCF MarginFCF / Revenue
5.2%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
2.25×
TTM Free Cash FlowTrailing 4 quarters
$80.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
$-66.9M
$46.5M
Q3 25
$12.1M
$51.4M
Q2 25
$5.4M
$41.6M
Q1 25
$-16.3M
$-3.0M
Q4 24
$34.8M
$63.1M
Q3 24
$50.0M
$68.0M
Q2 24
$44.8M
$46.3M
Free Cash Flow
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
$-69.0M
$24.3M
Q3 25
$11.4M
$38.0M
Q2 25
$4.8M
$33.6M
Q1 25
$-16.5M
$-15.4M
Q4 24
$33.3M
$40.6M
Q3 24
$49.6M
$59.8M
Q2 24
$44.4M
$39.6M
FCF Margin
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
-14.1%
5.2%
Q3 25
2.3%
7.7%
Q2 25
1.0%
7.0%
Q1 25
-3.6%
-3.5%
Q4 24
9.9%
9.1%
Q3 24
15.0%
12.9%
Q2 24
12.5%
8.6%
Capex Intensity
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
0.4%
4.7%
Q3 25
0.1%
2.7%
Q2 25
0.1%
1.6%
Q1 25
0.0%
2.8%
Q4 24
0.5%
5.1%
Q3 24
0.1%
1.8%
Q2 24
0.1%
1.4%
Cash Conversion
CLOV
CLOV
KWR
KWR
Q1 26
Q4 25
2.25×
Q3 25
1.69×
Q2 25
Q1 25
-0.24×
Q4 24
4.45×
Q3 24
2.10×
Q2 24
6.04×
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

KWR
KWR

Other$260.7M56%
Metalworking And Other$146.4M31%
Metals$61.4M13%

Related Comparisons